GenesisCare’s Florida and North Carolina cancer care clinics are to be sold to private equity-owned OneOncology, for a fraction of their former $1.5 billion-plus valuation.
The sale of those GenesisCare assets by Oaktree Capital Management for about $US200 million ($304 million) ends a painful restructure of the Australian cancer treatment company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.